Literature DB >> 27375027

p53 binds the mdmx mRNA and controls its translation.

A-S Tournillon1, I López1, L Malbert-Colas1, S Findakly1, N Naski1, V Olivares-Illana2, K Karakostis1, B Vojtesek3, K Nylander4, R Fåhraeus1,3,4.   

Abstract

MDMX and MDM2 are two nonredundant essential regulators of p53 tumor suppressor activity. MDM2 controls p53 expression levels, whereas MDMX is predominantly a negative regulator of p53 trans-activity. The feedback loops between MDM2 and p53 are well studied and involve both negative and positive regulation on transcriptional, translational and post-translational levels but little is known on the regulatory pathways between p53 and MDMX. Here we show that overexpression of p53 suppresses mdmx mRNA translation in vitro and in cell-based assays. The core domain of p53 binds the 5' untranslated region (UTR) of the mdmx mRNA in a zinc-dependent manner that together with a trans-suppression domain located in p53 N-terminus controls MDMX synthesis. This interaction can be visualized in the nuclear and cytoplasmic compartment. Fusion of the mdmx 5'UTR to the ovalbumin open reading frame leads to suppression of ovalbumin synthesis. Interestingly, the transcription inactive p53 mutant R273H has a different RNA-binding profile compared with the wild-type p53 and differentiates the synthesis of MDMX isoforms. This study describes p53 as a trans-suppressor of the mdmx mRNA and adds a further level to the intricate feedback system that exist between p53 and its key regulatory factors and emphasizes the important role of mRNA translation control in regulating protein expression in the p53 pathway.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27375027     DOI: 10.1038/onc.2016.236

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Authors:  Jijie Gu; Hidehiko Kawai; Linghu Nie; Hiroyuki Kitao; Dmitri Wiederschain; Aart G Jochemsen; John Parant; Guillermina Lozano; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

2.  Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism.

Authors:  B Galy; L Créancier; C Zanibellato; A C Prats; H Prats
Journal:  Oncogene       Date:  2001-03-29       Impact factor: 9.867

Review 3.  Mutant p53 gain-of-function in cancer.

Authors:  Moshe Oren; Varda Rotter
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02       Impact factor: 10.005

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

6.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

7.  MDM4 is a key therapeutic target in cutaneous melanoma.

Authors:  Agnieszka Gembarska; Flavie Luciani; Clare Fedele; Elisabeth A Russell; Michael Dewaele; Stéphanie Villar; Aleksandra Zwolinska; Sue Haupt; Job de Lange; Dana Yip; James Goydos; Jody J Haigh; Ygal Haupt; Lionel Larue; Aart Jochemsen; Hubing Shi; Gatien Moriceau; Roger S Lo; Ghanem Ghanem; Mark Shackleton; Federico Bernal; Jean-Christophe Marine
Journal:  Nat Med       Date:  2012-07-22       Impact factor: 53.440

8.  MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame.

Authors:  Pooja Mandke; Nicholas Wyatt; Jillian Fraser; Benjamin Bates; Steven J Berberich; Michael P Markey
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

9.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  Novel DNA-binding properties of the RNA-binding protein TIAR.

Authors:  Esther A Suswam; Yan Yan Li; Harry Mahtani; Peter H King
Journal:  Nucleic Acids Res       Date:  2005-08-09       Impact factor: 16.971

View more
  10 in total

1.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

2.  Transcription factors SOHLH1 and SOHLH2 coordinate oocyte differentiation without affecting meiosis I.

Authors:  Yong-Hyun Shin; Yu Ren; Hitomi Suzuki; Kayla J Golnoski; Hyo Won Ahn; Vasil Mico; Aleksandar Rajkovic
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

Review 3.  MDM4 alternative splicing and implication in MDM4 targeted cancer therapies.

Authors:  Jin Wu; Guanting Lu; Xinjiang Wang
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

Review 4.  The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer.

Authors:  Matilde Fregni; Yari Ciribilli; Joanna E Zawacka-Pankau
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

5.  p53-mediated suppression of BiP triggers BIK-induced apoptosis during prolonged endoplasmic reticulum stress.

Authors:  Ignacio López; Anne-Sophie Tournillon; Rodrigo Prado Martins; Konstantinos Karakostis; Laurence Malbert-Colas; Karin Nylander; Robin Fåhraeus
Journal:  Cell Death Differ       Date:  2017-06-16       Impact factor: 15.828

Review 6.  40 Years of Research Put p53 in Translation.

Authors:  Virginie Marcel; Flora Nguyen Van Long; Jean-Jacques Diaz
Journal:  Cancers (Basel)       Date:  2018-05-21       Impact factor: 6.639

7.  Preferential translation of p53 target genes.

Authors:  Miharu Hisaoka; Johanna Schott; Toman Bortecen; Doris Lindner; Jeroen Krijgsveld; Georg Stoecklin
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

Review 8.  DNA and RNA Binding Proteins: From Motifs to Roles in Cancer.

Authors:  Ondrej Bonczek; Lixiao Wang; Sivakumar Vadivel Gnanasundram; Sa Chen; Lucia Haronikova; Filip Zavadil-Kokas; Borivoj Vojtesek
Journal:  Int J Mol Sci       Date:  2022-08-18       Impact factor: 6.208

Review 9.  The long and the short of it: the MDM4 tail so far.

Authors:  Sue Haupt; Javier Octavio Mejía-Hernández; Reshma Vijayakumaran; Simon P Keam; Ygal Haupt
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

Review 10.  p53 mRNA Metabolism Links with the DNA Damage Response.

Authors:  Sivakumar Vadivel Gnanasundram; Ondrej Bonczek; Lixiao Wang; Sa Chen; Robin Fahraeus
Journal:  Genes (Basel)       Date:  2021-09-20       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.